T. Alhaidari, Asmma H. Majeed, Sahar Al-Jassani, Hayder Adnan Fawzi, Lewai S. Abdulaziz, F. El Kak
{"title":"Safety profile of immediate post-partum intrauterine device insertion during caesarean delivery – a clinical trial with three years of follow up","authors":"T. Alhaidari, Asmma H. Majeed, Sahar Al-Jassani, Hayder Adnan Fawzi, Lewai S. Abdulaziz, F. El Kak","doi":"10.47723/kcmj.v18i1.797","DOIUrl":null,"url":null,"abstract":"Background: Many countries recommend the use of long-acting reversible contraceptive intrauterine device immediately after cesarean delivery. The cesarean delivery rate in Iraqi public hospitals is 32.2% and may reach 85.8% in private hospitals. Immediate post-partum intrauterine device insertion at cesarean is rarely done in Iraq.\nObjectives: To assess the safety and practicality of immediate post-partum intrauterine device insertion during cesarean delivery for family planning and pregnancy spacing in Iraqi women.\nSubjects and Methods: A single arm clinical trial included 150 eligible women who attended Al-Elwiyah Maternity Teaching Hospital or Al Hayat Rahibat Hospital for term delivery. A copper intrauterine device was placed in the uterine cavity immediately after delivery of the placenta during cesarean delivery. The intrauterine device was fixed in place at the fundus using an absorbable suture. Patients were followed up at six weeks, then annually for three years.\nResults: Expulsion of the intrauterine device was not reported by any of the participants. The most-reported complaints in the first twelve months of intrauterine device placement were abdominal pain, abnormal vaginal discharge, and heavy menstrual blood loss, however, none were statically significant (P= 0.256). After the first year, there was a significant reduction in the frequency of complaints (P= 0.002). Only 7.33% (95% CI: 6.92–7.75%) of the patient requested intrauterine device removal within the three years. The main reason was to plan a new pregnancy followed by recurrent infection associated with uncontrolled diabetes mellitus. Diabetes was a significant predictor for immediate post-partum intrauterine device removal, P= 0.049.\nConclusion: The intrauterine device placement during cesarean delivery with suture fixation is a safe procedure with a zero-expulsion rate and is an effective reversible long-term contraceptive method.","PeriodicalId":34748,"journal":{"name":"mjlh klyh Tb lkndy","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"mjlh klyh Tb lkndy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47723/kcmj.v18i1.797","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Many countries recommend the use of long-acting reversible contraceptive intrauterine device immediately after cesarean delivery. The cesarean delivery rate in Iraqi public hospitals is 32.2% and may reach 85.8% in private hospitals. Immediate post-partum intrauterine device insertion at cesarean is rarely done in Iraq.
Objectives: To assess the safety and practicality of immediate post-partum intrauterine device insertion during cesarean delivery for family planning and pregnancy spacing in Iraqi women.
Subjects and Methods: A single arm clinical trial included 150 eligible women who attended Al-Elwiyah Maternity Teaching Hospital or Al Hayat Rahibat Hospital for term delivery. A copper intrauterine device was placed in the uterine cavity immediately after delivery of the placenta during cesarean delivery. The intrauterine device was fixed in place at the fundus using an absorbable suture. Patients were followed up at six weeks, then annually for three years.
Results: Expulsion of the intrauterine device was not reported by any of the participants. The most-reported complaints in the first twelve months of intrauterine device placement were abdominal pain, abnormal vaginal discharge, and heavy menstrual blood loss, however, none were statically significant (P= 0.256). After the first year, there was a significant reduction in the frequency of complaints (P= 0.002). Only 7.33% (95% CI: 6.92–7.75%) of the patient requested intrauterine device removal within the three years. The main reason was to plan a new pregnancy followed by recurrent infection associated with uncontrolled diabetes mellitus. Diabetes was a significant predictor for immediate post-partum intrauterine device removal, P= 0.049.
Conclusion: The intrauterine device placement during cesarean delivery with suture fixation is a safe procedure with a zero-expulsion rate and is an effective reversible long-term contraceptive method.
背景:许多国家建议在剖宫产后立即使用长效可逆避孕宫内节育器。伊拉克公立医院的剖宫产率为32.2%,私立医院可能达到85.8%。在伊拉克很少在剖宫产时立即插入产后宫内节育器。目的:评估在伊拉克妇女计划生育和间隔妊娠期间在剖宫产后立即插入宫内节育器的安全性和实用性。受试者和方法:一项单臂临床试验包括150名参加Al-Elwiyah妇产教学医院或Al Hayat Rahibat医院进行足月分娩。剖宫产时,在胎盘分娩后立即将铜宫内节育器放入宫腔内。使用可吸收缝线将宫内节育器固定在眼底。患者在六周时接受随访,然后每年随访三年。结果:没有任何参与者报告宫内节育器被取出。在放置宫内节育器的前12个月内,报告最多的投诉是腹痛、阴道异常分泌物和然而,月经失血过多,没有一个是静态显著的(P=0.256)。第一年后投诉频率(P=0.002)。在三年内,只有7.33%(95%置信区间:6.92–7.75%)的患者要求取出宫内节育器。主要原因是计划再次怀孕,然后再进行与糖尿病失控相关的复发性感染糖尿病。糖尿病结论:剖宫产术中放置宫内节育器缝合固定是一种安全的、零排出率的方法,是一种有效的、可逆的长期避孕方法。